NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Finnrick
Free Test
← PT-141 vendors

BeiBangAnPT-141

3 testslatest 29 Dec 2025
Message on WhatsApp+18502420473Monitor this vendor24/7 safety alerts · Finnrick Gold
Peptide testing

Ordered PT-141 from BeiBangAn? Mail in a sample (US only) and let us test it.

Test my supply
+6 more ↓
60%
Finnrick rating
#36 of 47 PT-141 vendors
1 of 3 classifiable tests passed
natural 33%
methodology · Purity focus
Finnrick analysis · PT-141

BeiBangAn's Purity focus record is strongest in higher-volume Retatrutide and Tirzepatide, where recent identity and purity evidence has improved despite earlier misses. Weakness is dispersed but clearest in PT-141 and Tesamorelin, with fill volatility, missing batch IDs on some vials, and sparse product-level records leaving uncertainty.

methodology →
vendor intelligence report
Vendor Intelligence Report: BeiBangAn

BBA’s public COA page now exists, but the certificate trail stops short of vial-level traceability. The report maps Hostinger staging fingerprints, LNpeptide build artifacts, lapsed domains, and Telegram copycat risk.

33 pages7 risk factors assessed12 Nov 2026
read the report
Peptides
14 rated · tap to focus
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.10
84%
5
2
Retatrutide
$0.70
77%
37
3
Tirzepatide
$0.34
76%
20
4
Semaglutide
$0.45
69%
4
5
PT-141selected
-
60%
3
6
BPC-157
$0.70
54%
4
7
Tesamorelin
-
47%
1
8
Cagrilintide
$1.85
-
0
9
CJC-1295
-
-
0
10
HGH
-
-
0
11
Ipamorelin
-
-
0
12
Melanotan II
$0.55
-
0
13
Sermorelin
$1.20
-
0
14
TB-500
$1.50
-
0
Contact channels
5 channels on file
WhatsApp+18502420473WhatsApp+85266160827Websitet.meWebsitebeibanganpeptides.comEmailbeibanganpep@gmail.com
Rating trend
PT-141 from this vendor, after each test
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%2 Dec 2025: 53%17 Dec 2025: 57%29 Dec 2025: 53%12 Nov 2026: current 60%53%60%Dec 25Nov 26
Showing PT-141 tests only
BeiBangAn PT-141 test history
3 tests · 1 pass · 2 fail· Purity focus
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
29 Dec 2025Fail
6rmkd4r
Tested
lab nameView COA
17 Dec 2025Pass
mjmc3ev
Tested
lab nameView COA
2 Dec 2025Fail
u9nua5x
Tested
lab nameView COA

About BeiBangAn test results from Finnrick

BeiBangAn is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 7 peptides and 74 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible BeiBangAn peptides in this dataset are BPC-157 (4 tests), GHK-Cu (5 tests) and PT-141 (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 74 recent tests. It also includes 1 correction related to this vendor.

Corrections
1 corrections
2026-03-11
Lab correction
Requester asked for a review, the lab issued an updated COA: blank correction was not accounted for in the previous analysis, resulting in an incorrect purity reading of 97.4%.
Peptide testing

Ordered PT-141 from BeiBangAn? Mail in a sample (US only) and let us test it.

Test my supply